Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News CEL-SCI Corp CVM

Healthcare Biotechnology
CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. The Company is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:CVM)

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

Business Wire 3 days ago

CEL-SCI's LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology

Business Wire March 19, 2024

CEL-SCI Corporation Issues Letter to Shareholders

Business Wire March 6, 2024

CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results

Business Wire February 15, 2024

CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock

Business Wire February 13, 2024

CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock

Business Wire February 9, 2024

CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug

Business Wire February 6, 2024

European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®

Business Wire January 31, 2024

CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments

Business Wire December 22, 2023
View More News ››

Opinion & Analysis (NYSEAM:CVM)

Alternative, green energy stock picks

J.W. Cotton December 2, 2009

Stock picks with insider buying

J.W. Cotton November 20, 2008

Dividend and speculative stock picks

J.W. Cotton October 28, 2008
View More Opinion ››

Bullboard Posts (NYSEAM:CVM)

Why CEL-SCI Corporation (CVM) Shares Are Diving | Benzinga

Breaking News: $CVM Why CEL-SCI Corporation (CVM) Shares Are Diving | BenzingaCEL-SCI Corporation (NASDAQ:CVM) shares are trading lower...
whytestocks - February 9, 2024

Excellent YT analysis on Cel-Sci!

https://youtu.be/i_CYM93Vnb8?si=ZaCOw3Hxek8yvvRe
BryceCanada - January 30, 2024

Coronavirus

Coronavirus most likely helped push this over the limit.  Now they can digest the numbers which can make or break this company. ...
Floridas2000 - May 9, 2020

Some folks just don't get it

Hit $16.85 and board is empty.  Pity
MarineJumper - February 19, 2020

RE:For anyone interested ....this might be new standard of care

It's obvious someone knows something here.  If Phase 3 gets approved this year, it would be very good news.
Floridas2000 - January 22, 2020

For anyone interested ....this might be new standard of care

https://augustafreepress.com/a-story-of-resilience-vienna-based-cel-sci-continues-to-move-forward/
MarineJumper - January 17, 2020
View more Bullboard ››

Bocana Resources Corp.

Bocana Resources Corp.

Bocana is a mineral exploration company focused on the acquisition, exploration and development of mineral properties in ...
View More »